![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Multiple Sclerosis |
Free Subscription
1 Ann Neurol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Multiple Sclerosis is free of charge.
COMBAT-MS: A Population-Based Observational Cohort Study Addressing the
Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab.
Ann Neurol. 2024 Jun 25. doi: 10.1002/ana.27012.
PubMed
Abstract available
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying
therapy prescribing patterns during the COVID-19 pandemic.
J Neurol. 2024 Jun 27. doi: 10.1007/s00415-024-12518.
PubMed
Abstract available
Evaluation of machine learning-based classification of clinical impairment and
prediction of clinical worsening in multiple sclerosis.
J Neurol. 2024 Jun 23. doi: 10.1007/s00415-024-12507.
PubMed
Abstract available
Three-dimensional EPI with shot-selective CAIPIRIHANA for rapid high-resolution
quantitative susceptibility mapping at 3 T.
Magn Reson Med. 2024;92:997-1010.
PubMed
Abstract available
Brain and cervical spinal cord MRI correlates of sensorimotor impairment in
patients with multiple sclerosis.
Mult Scler. 2024 Jun 24:13524585241260145. doi: 10.1177/13524585241260145.
PubMed
Abstract available
Impact of multiple sclerosis comorbidities on quality of life and job activity.
Mult Scler. 2024 Jun 24:13524585241260550. doi: 10.1177/13524585241260550.
PubMed
Abstract available
Konectom cognitive processing speed test enables reliable remote, unsupervised
cognitive assessment in people with multiple sclerosis: Exploring the use of
substitution time as a novel digital outcome measure.
Mult Scler. 2024 Jun 24:13524585241259650. doi: 10.1177/13524585241259650.
PubMed
Abstract available
All women with multiple sclerosis should start hormone replacement therapy at
menopause unless contraindicated: No.
Mult Scler. 2024 Jun 22:13524585241254987. doi: 10.1177/13524585241254987.
PubMed
All women with multiple sclerosis should start hormone replacement therapy at
menopause unless contraindicated: Commentary.
Mult Scler. 2024 Jun 22:13524585241254989. doi: 10.1177/13524585241254989.
PubMed
Escalation to Anti-CD20 Treatment for Multiple Sclerosis Following
Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
Neurol Clin Pract. 2024;14:e200330.
PubMed
Abstract available
[XVI Post-ECTRIMS Meeting: review of the new developments presented at the 2023
ECTRIMS Congress (I)].
Rev Neurol. 2024;79:21-29.
PubMed
Abstract available
Thank you for your interest in scientific medicine.